34.21
+0.11
(0.32%)
Real-time:
1:38PM EDT
NYSE
real-time data -
Disclaimer
Currency in USD
| Range | 34.08 - 34.35 |
| 52 week | 23.77 - 35.61 |
| Open | 34.13 |
| Vol / Avg. | 458,861.00/1.82M |
| Mkt cap | 7.52B |
| P/E | 20.78 |
| Div/yield | - |
| EPS | 1.65 |
| Shares | 219.81M |
| Beta | 0.95 |
| Inst. own | 94% |
Key stats and ratios
| Q1 (Mar '13) | 2012 | |
| Net profit margin | 9.32% | 10.03% |
| Operating margin | 14.98% | 15.95% |
| EBITD margin | - | 22.37% |
| Return on average assets | 3.93% | 4.33% |
| Return on average equity | 6.14% | 7.01% |
| Employees | 15,000 | - |
| Carbon Disclosure Rating | - | - |
Address
3750 Torrey View Court
SAN DIEGO, CA 92130
United States - Map
+1-858-6172000 (Phone)
+1-302-6555049 (Fax)
SAN DIEGO, CA 92130
United States - Map
+1-858-6172000 (Phone)
+1-302-6555049 (Fax)
Website links
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters
Discussion Group - Google Finance
Volume delayed by 15 mins.
Advertisement
Description
CareFusion Corporation (CareFusion) is a global medical technology company. The Company operates in two segments: Medical Systems and Procedural Solutions. The Medical Systems segment is organized around its medical equipment businesses. The Company�s Medical Systems segment�s business units and product lines include Infusion Systems, Dispensing Technologies, and Respiratory Technologies. The Procedural Solutions segment is organized around the Company�s disposable products and reusable surgical instruments businesses. The Company�s Procedural Solutions segment�s business units and product lines include Infection Prevention, Medical Specialties and Specialty Disposables. In August 2011, the Company acquired Rowa. In June 2012, the Company acquired U.K. Medical Limited. In July 2012, Natus Medical, Inc. acquired the Nicolet neurodiagnostic business from CareFusion.
Officers and directors
| Kieran T. Gallahue | Chairman of the Board, Chief Executive Officer | |
| James F. Hinrichs | Chief Financial Officer | |
| Vivek Jain | President - Procedural Solutions | |
| Thomas J. Leonard | President - Medical Systems | |
| Joan Stafslien | Executive Vice President, Chief Compliance Officer, General Counsel, Secretary | |
| Roger Marchetti | Executive Vice President - Human Resources | |
| Donald Abbey | Executive Vice President - Quality, Regulatory and Medical Affairs | |
| Gordon La Fortune | Executive Vice President - EMEA/APAC Commercial Operations and Global Infusion Disposables | |
| Jean Maschal | Senior Vice President, Chief Accounting Officer, Controller | |
| Philip L. Francis | Non-Employee Independent Director |